A carregar...
Light activated, In situ Forming Gel for Sustained Suprachoroidal Delivery of Bevacizumab
PURPOSE: To develop a light activated polycaprolactone dimethacrylate and hydroxyethyl methacrylate based gel network that sustains the release of stable, active bevacizumab (an anti-VEGF antibody used to treat choroidal neovascularization) and to assess sustained ex vivo delivery in rabbit eyes and...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4003910/ https://ncbi.nlm.nih.gov/pubmed/23734705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/mp300716t |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|